Hyo Jung Nam

机构：Hanall Biopharma (South Korea), RBio (South Korea)

发表论文 35 篇 · 总被引 740 次 · h-index 15

代表论文

Epigallocatechin-3-gallate attenuates head and neck cancer stem cell traits through suppression of Notch pathway (2013 · European Journal of Cancer · 被引 113)
Benefit of Targeting a LDL (Low-Density Lipoprotein) Cholesterol <70 mg/dL During 5 Years After Ischemic Stroke (2020 · Stroke · 被引 59)
NRF2 Knockdown Resensitizes 5-Fluorouracil-Resistant Pancreatic Cancer Cells by Suppressing HO-1 and ABCG2 Expression (2020 · International Journal of Molecular Sciences · 被引 42)
An adjuvanted zoster vaccine elicits potent cellular immune responses in mice without QS21 (2022 · npj Vaccines · 被引 30)
Intracranial Hemorrhage in the TST Trial (2021 · Stroke · 被引 25)
Valproic acid suppresses the self-renewal and proliferation of head and neck cancer stem cells (2015 · Oncology Reports · 被引 22)